| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |